Criminal Law • Felonies • White Collar Crime • Criminal Defense • General Practice • Driving While Intoxicated • Personal Injury • Real Estate • Business Litigation
Jan 1998 to 2000 Independent Computer ConsultantWalt Disney World
May 2005 to Jan 2006 Crowd Control / Janitorial / Seater (Internship)Best Buy
Nov 2001 to Jun 2002 Merchandising AssociateSouthside High School
May 1999 to Aug 1999 Janitor
Education:
Phoenix University Aug 2012 B.S. in Computer Science Information TechnologyUniversity of Arkansas May 2009 HistoryDale Carnegie Aug 2001 Business and Professional Speaking
- Princeton NJ, US George V. Delucca - Pennington NJ, US Ashvinikumar V. Gavai - Princeton Junction NJ, US Claude A. Quesnelle - Skillman NJ, US Patrice Gill - Levittown PA, US Daniel O'Malley - New Hope PA, US Wayne Vaccaro - Yardley PA, US Francis Y. Lee - Yardley PA, US Mikkel V. DeBenedetto - Middletown CT, US Andrew P. Degnan - Rocky Hill CT, US Haiquan Fang - Madison CT, US Matthew D. Hill - Wallingford CT, US Hong Huang - Durham CT, US William D. Schmitz - Cheshire CT, US Wen-Ching Han - Newtown PA, US John S. Tokarski - Princeton NJ, US Sunil Kumar Mandal - Bangalore, IN
International Classification:
C07D 471/04 A61K 31/437
Abstract:
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
- Princeton NJ, US George V. Delucca - Pennington NJ, US Ashvinikumar V. Gavai - Princeton Junction NJ, US Claude A. Quesnelle - Skillman NJ, US Patrice Gill - Levittown PA, US Daniel O'Malley - New Hope PA, US Wayne Vaccaro - Yardley PA, US Francis Y. Lee - Yardley PA, US Mikkel V. DeBenedetto - Middletown CT, US Andrew P. Degnan - Rocky Hill CT, US Haiquan Fang - Madison CT, US Matthew D. Hill - Wallingford CT, US Hong Huang - Durham CT, US William D. Schmitz - Cheshire CT, US Wen-Ching Han - Newtown PA, US John S. Tokarski - Princeton NJ, US Sunil Kumar Mandal - Bangalore, Karnataka, IN
The present invention is directed to tricyclic compounds (I), pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
- Princeton NJ, US George V. Delucca - Pennington NJ, US Ashvinikumar V. Gavai - Princeton Junction NJ, US Claude A. Quesnelle - Skillman NJ, US Patrice Gill - Levittown PA, US Daniel O'Malley - New Hope PA, US Wayne Vaccaro - Yardley PA, US Francis Y. Lee - Yardley PA, US Mikkel V. DeBenedetto - Middletown CT, US Andrew P. Degnan - Rocky Hill CT, US Haiquan Fang - Madison CT, US Matthew D. Hill - Wallingford CT, US Hong Huang - Durham CT, US William D. Schmitz - Cheshire CT, US Wen-Ching Han - Newtown PA, US John S. Tokarski - Princeton NJ, US Sunil Kumar Mandal - Bangalore, IN
International Classification:
C07D 471/04 A61K 31/437
Abstract:
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
- Princeton NJ, US Yufen Zhao - Pennington NJ, US Daniel O'Malley - New Hope PA, US Claude A. Quesnelle - Skillman NJ, US Brian E. Fink - Yardley PA, US Derek J. Norris - Hopewell NJ, US Wen-Ching Han - Newtown PA, US George V. DeLucca - Pennington NJ, US
Disclosed are compounds of Formula (I) and/or salts thereof: (I) wherein: Ris CHCHCF; Ris CH(cyclopropyl), CH(CH)(cyclopropyl), or CHCHCH; Ris H, CH, or R; Ris H or R; and R, R, R, R, R, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer. The compounds of Formula (I) also include prodrugs of the Notch inhibitor compounds.
- Princeton NJ, US Weifang Shan - Princeton NJ, US James Aaron Balog - Lambertsville NJ, US Claude A. Quesnelle - Skillman NJ, US Wen-Ching Han - Newtown PA, US George V. DeLucca - Pennington NJ, US Daniel O'Malley - New Hope PA, US Brian E. Fink - Yardley PA, US
Disclosed are compounds of Formula (I): wherein: Ris phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; Ris H, CH, CH(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl: and R, R, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.